Impact of Physical Exercise on Melanoma Hallmarks: Current Status of Preclinical and Clinical Research
Schematic drawing of melanoma hallmarks critically depending on the hypoxic state that accompanies the growth of the tumor mass, i.e., invasion and metastasis, neoangiogenesis, and reprogramming energy metabolism (upper part): the increase in tumor mass causes a decrease of oxygen availability and upregulation of proangiogenic (VEGF-A) and prometastatic (MMPs) factors, under the stimulation, among others, of the PI3K/AKT pathway. This response, leading to pathological angiogenesis and metastatic spreading, is crucial for the tumor to overcome hypoxia. However, the new blood vessels show a chaotic and tortuous structure. Moreover, cancer cells modify their metabolism and use glycolysis even under aerobic conditions (“Warburg effect”), with consequent increased production of lactate and acidification of the tumor microenvironment. Effects of physical activity on melanoma invasion and metastasis, neoangiogenesis, and reprogramming energy metabolism (lower part): an altered expression of soluble factors responsible for vascular remodeling, i.e., NFAT and TSP-1, was observed by means of in vitro experimental conditions that mimic the increase in blood flow observed in vivo in association with physical exercise. Moreover, upregulation of VCAM-1 in endothelial cells and a significant vessel normalization were observed in vivo in the tumor-associated vasculature of melanoma murine models performing treadmill exercise, compared to sedentary control animals. The consequent reduced invasiveness limits metastatic spreading. Melanoma metastasis also seems to be hampered by mTOR mediated protective metabolic changes induced by physical activity, like an increase in glucose metabolism, as evidenced both in animals and in humans. Abbreviations. Glut: glucose transporter; IGF-1: insulin-like growth factor-1; NFAT: nuclear factor of activated T cells; MMPs: matrix metalloproteinases; TME: tumor microenvironment; TSP-1: thrombospondin-1; VCAM-1: vascular cell adhesion molecule-1; VEGF-A: vascular endothelial growth factor A; VEGFR-1: vascular endothelial growth factor receptor 1.
Publication
Impact of Physical Exercise on Melanoma Hallmarks: Current Status of Preclinical and Clinical Research. (2024) Claudia Ceci, et al. J Cancer. 2024;15(1):1-19. Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP1 | 4312 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP2 | 4313 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP3 | 4314 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP7 | 4316 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP8 | 4317 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP9 | 4318 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP10 | 4319 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP11 | 4320 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP12 | 4321 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP13 | 4322 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP14 | 4323 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP15 | 4324 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP16 | 4325 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP17 | 4326 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP19 | 4327 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP20 | 9313 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP21 | 118856 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP23B | 8510 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP24 | 10893 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP25 | 64386 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP26 | 56547 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP27 | 64066 |
| Homo sapiens | Primates | MMPs | MMP | famplex_relations | MMP28 | 79148 |
| Homo sapiens | Primates | VEGFR-1 | VEGFR-1 | ncbigene_synonym | FLT1 | 2321 |
| Homo sapiens | Primates | VEGF-A | VEGFA | ncbigene_symbol | VEGFA | 7422 |
| Homo sapiens | Primates | NFAT | NFAT | famplex_relations | NFATC1 | 4772 |
| Homo sapiens | Primates | NFAT | NFAT | famplex_relations | NFATC2 | 4773 |
| Homo sapiens | Primates | NFAT | NFAT | famplex_relations | NFATC3 | 4775 |
| Homo sapiens | Primates | NFAT | NFAT | famplex_relations | NFATC4 | 4776 |
| Homo sapiens | Primates | NFAT | NFAT | famplex_relations | NFAT5 | 10725 |
| Homo sapiens | Primates | VCAM-1 | VCAM1 | ncbigene_symbol | VCAM1 | 7412 |
| Homo sapiens | Primates | IGF-1 | IGF1 | ncbigene_symbol | IGF1 | 3479 |
| Homo sapiens | Primates | Glut | GLUT | ncbigene_synonym | SLC2A1 | 6513 |
| Homo sapiens | Primates | Glut2 | GLUT2 | ncbigene_synonym | SLC2A2 | 6514 |
| Homo sapiens | Primates | Glut4 | GLUT4 | ncbigene_synonym | SLC2A4 | 6517 |
| Homo sapiens | Primates | Fat | FAT | ncbigene_synonym | CD36 | 948 |
| Homo sapiens | Primates | Fat | FAT | ncbigene_synonym | FAT1 | 2195 |
| Homo sapiens | Primates | mTOR | MTOR | ncbigene_symbol | MTOR | 2475 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| molecules | molecules | chebi:25367 | ||
| Glucose | Glucose | aldehydo-D-glucose | chebi:42758 | |
| Pyruvate | pyruvate | pyruvate | chebi:15361 | |
| Lactate | lactate | lactate | chebi:24996 | |
| mRNA | mRNA | mRNA | chebi:33699 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|